161 related articles for article (PubMed ID: 35313488)
1. Enhanced circulation longevity and pharmacodynamics of metformin from surface-modified nanostructured lipid carriers based on solidified reverse micellar solutions.
Kenechukwu FC; Isaac GT; Nnamani DO; Momoh MA; Attama AA
Heliyon; 2022 Mar; 8(3):e09100. PubMed ID: 35313488
[TBL] [Abstract][Full Text] [Related]
2. Potential enhancement of metformin hydrochloride in solidified reverse micellar solution-based PEGylated lipid nanoparticles targeting therapeutic efficacy in diabetes treatment.
Kenechukwu FC; Nnamani DO; Duhu JC; Nmesirionye BU; Momoh MA; Akpa PA; Attama AA
Heliyon; 2022 Mar; 8(3):e09099. PubMed ID: 35309393
[TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of novel solid lipid microparticles as a sustained release system for the delivery of metformin hydrochloride.
Momoh MA; Kenechukwu FC; Attama AA
Drug Deliv; 2013; 20(3-4):102-11. PubMed ID: 23650987
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured Lipid Carriers Loaded with Baicalin: An Efficient Carrier for Enhanced Antidiabetic Effects.
Shi F; Wei Z; Zhao Y; Xu X
Pharmacogn Mag; 2016; 12(47):198-202. PubMed ID: 27601850
[TBL] [Abstract][Full Text] [Related]
5. G5-PEG PAMAM dendrimer incorporating nanostructured lipid carriers enhance oral bioavailability and plasma lipid-lowering effect of probucol.
Qi R; Li YZ; Chen C; Cao YN; Yu MM; Xu L; He B; Jie X; Shen WW; Wang YN; van Dongen MA; Liu GQ; Banaszak Holl MM; Zhang Q; Ke X
J Control Release; 2015 Jul; 210():160-8. PubMed ID: 26003044
[TBL] [Abstract][Full Text] [Related]
6. Intranasal artesunate-loaded nanostructured lipid carriers: A convenient alternative to parenteral formulations for the treatment of severe and cerebral malaria.
Agbo CP; Ugwuanyi TC; Ugwuoke WI; McConville C; Attama AA; Ofokansi KC
J Control Release; 2021 Jun; 334():224-236. PubMed ID: 33894303
[TBL] [Abstract][Full Text] [Related]
7. Improved antimalarial activity of caprol-based nanostructured lipid carriers encapsulating artemether-lumefantrine for oral administration.
Akpa PA; Ugwuoke JA; Attama AA; Ugwu CN; Ezeibe EN; Momoh MA; Echezona AC; Kenechukwu FC
Afr Health Sci; 2020 Dec; 20(4):1679-1697. PubMed ID: 34394228
[TBL] [Abstract][Full Text] [Related]
8. Effect of the Surfactant and Liquid Lipid Type in the Physico-chemical Characteristics of Beeswax-based Nanostructured Lipid Carrier (NLC) of Metformin.
Qushawy M
Pharm Nanotechnol; 2021; 9(3):200-209. PubMed ID: 33618652
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
Dudhipala N; Janga KY; Gorre T
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
[TBL] [Abstract][Full Text] [Related]
10. Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks.
Elmowafy M; Ibrahim HM; Ahmed MA; Shalaby K; Salama A; Hefesha H
Drug Deliv; 2017 Nov; 24(1):932-941. PubMed ID: 28617150
[TBL] [Abstract][Full Text] [Related]
11. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers.
Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X
AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361
[TBL] [Abstract][Full Text] [Related]
12. Solid lipid micro-dispersions (SLMs) based on PEGylated solidified reverse micellar solutions (SRMS): a novel carrier system for gentamicin.
Kenechukwu FC; Momoh MA; Nnamani PO; Attama AA
Drug Deliv; 2015; 22(6):710-22. PubMed ID: 24724962
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: Pharmacological and docking studies.
Ahmad A; Abuzinadah MF; Alkreathy HM; Banaganapalli B; Mujeeb M
PLoS One; 2018; 13(3):e0193451. PubMed ID: 29558494
[TBL] [Abstract][Full Text] [Related]
14. Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects.
Chen X; Zhang Y; Zhao P; Chen Y; Zhou Y; Wang S; Yin L
Drug Dev Ind Pharm; 2020 Jan; 46(1):57-69. PubMed ID: 31813288
[TBL] [Abstract][Full Text] [Related]
15. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.
Ranpise NS; Korabu SS; Ghodake VN
Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002
[TBL] [Abstract][Full Text] [Related]
16. PEGylated aceclofenac solid lipid microparticles homolipid-based solidified reverse micellar solutions for drug delivery.
Ugwu CE; Oraeluno JN; Eze KC; Ezenma CO; Nwankwo AO
Heliyon; 2022 Apr; 8(4):e09247. PubMed ID: 35434391
[TBL] [Abstract][Full Text] [Related]
17. Enhanced Pharmacokinetic Activity of Zotepine via Nanostructured Lipid Carrier System in Wistar Rats for Oral Application.
Tirumalesh C; Suram D; Dudhipala N; Banala N
Pharm Nanotechnol; 2020; 8(2):148-160. PubMed ID: 32096755
[TBL] [Abstract][Full Text] [Related]
18. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables.
Rathod VR; Shah DA; Dave RH
Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896
[TBL] [Abstract][Full Text] [Related]
19. Topical phenytoin nanostructured lipid carriers: design and development.
Motawea A; Borg T; Abd El-Gawad AEH
Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-coated nanostructured lipid carriers of fenofibrate with enhanced oral bioavailability and efficacy.
Pyo YC; Tran P; Kim DH; Park JS
Colloids Surf B Biointerfaces; 2020 Dec; 196():111331. PubMed ID: 32906001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
